Clinical Trial Update: Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on transplanting hearts with antiviral therapy to manage Hepatitis C in recipients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hepatitis C

Snippet

Sponsor: Baylor Research Institute | Conditions: Heart Failure | Phase 2 | Status: RECRUITING